H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $11.00 price target on Innate Pharma S.A. (NASDAQ: IPHA).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE